Dittrich, Anne T. M. https://orcid.org/0000-0002-7722-4585
Kroeze, Yvet https://orcid.org/0009-0002-2339-8237
Willemsen, Michel A. A. P. https://orcid.org/0000-0001-7860-7791
Draaisma, Jos M. Th. https://orcid.org/0000-0003-4829-6173
van Puijenbroek, Eugène P. https://orcid.org/0000-0002-2236-1398
te Loo, D. Maroeska W. M. https://orcid.org/0000-0001-6308-4801
Article History
Accepted: 13 July 2025
First Online: 3 August 2025
Declarations
:
: Open access funding provided by Radboud University Medical Center.
: Eugène van Puijenbroek is an Editorial Board member of Drug Safety . Eugène van Puijenbroek was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. All other authors have no conflicts to declare.
: All results are available upon reasonable request. All requests should be submitted in writing to the corresponding author.
: This study was submitted to the local ethics committee (CMO Radboudumc; file no. 2018-5070), and it was approved.
: Completion of the questionnaire was considered informed consent.
: Not applicable.
: Not applicable; survey responders are anonymous and not known by the authors
: A.D., J.D., E.v.P., and M.t.L. contributed to the study conception and design. A.D., Y.K., M.W., J.D., E.v.P., and M.t.L. approved the final version of the survey. A.D. and Y.K. contributed to the data analysis. A.D., Y.K., M.W., J.D., E.v.P., and M.t.L. contributed to interpretation of the data. A.D. and M.t.L. contributed to drafting and revising of the manuscript. All authors read and approved the final version.